National Estimate of the cost of Parkinson’s Disease Medications

Slides:



Advertisements
Similar presentations
HEALTH CARE ORGANIZATION AND MANAGEMENT: THE IMPACT OF HEALTH REFORM HOWARD S. BERLINER, Sc.D.
Advertisements

1.03 Healthcare Finances Understand healthcare agencies, finances, and trends Healthcare Finances Government Finances Private Finances 2.
Introduction to Health Economics. Per Capita Total Current Health Care Expenditures, U.S. and Selected Countries, 2007 ^OECD estimate. *Differences in.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Trends in the.
The Impact of National Health Reform on Adults with Mental Disorders Rachel L. Garfield, Ph.D. Department of Health Policy & Management, University of.
Disparities in the Adequacy of Depression Treatment in the United States Jeffrey S. Harman, Ph.D. University of Florida Mark J. Edlund, M.D., Ph.D. John.
The Impact of Health Expenses on Older Women ’ s Financial Security Juliette Cubanski, Ph.D. The Henry J. Kaiser Family Foundation AcademyHealth 2007 Annual.
Purpose Results A National Estimate of the Cost of Nursing Home Care for Patients with Parkinson ’ s disease Katherine Anderson, Richard Faris, Lawrence.
Disparity Implications of the Eligibility Criteria for Medication Therapy Management Services among the Non-Medicare Population Junling Wang, Ph.D., Lawrence.
Meghan Bohren.  Primary care physicians consist of: ◦ Family physicians/general practioners ◦ General internists ◦ General pediatricians ◦ Geriatricians.
Obesity, Medication Use and Expenditures among Nonelderly Adults with Asthma Eric M. Sarpong AHRQ Conference September 10, 2012.
Differences in Access to Care for Asian and White Adults Merrile Sing, Ph.D. September 8, 2008.
1.03 Healthcare Finances. Health Insurance Plans Premium-The periodic amount paid to an insurance company for healthcare or prescription drugs Deductible-Amount.
Presented at The 129th Annual Meeting of the American Public Health Association Atlanta, GA, October 21–25, 2001 Presented by Amanda A. Honeycutt Linda.
Purpose Methods Results Conclusions A National Estimate of Direct and Indirect Costs of Parkinson’s Disease Using Retrospective Database Analysis The University.
Medical Expenditure Panel Survey (MEPS), Health Care Expenditures for the Elderly with Chronic Conditions in 2012 Jeffrey Rhoades.
Co-occurring Mental Illness and Healthcare Utilization and Expenditures Among Adults with Obesity and Chronic Physical Illness Chan Shen, MA. MS. Usha.
Chronic Condition Predictors of Emergency Room Expenditures Among Uninsured Americans Aged Julie Summey, Lu Shi, PhD Department of Public Health.
Utility of an overlapping panel design in the MEPS Steven B. Cohen, Ph.D.
Out of Pocket Burdens for Health Care: Insured, Uninsured, and Underinsured Jessica Banthin, Ph.D. September 23, 2008.
1.03 Healthcare Finances.
Methods of Payment for Healthcare
Methods of Payment for Healthcare
Clinical Medical Assisting
1.03 Healthcare Finances.
Percent with unmet medical need
Among People with High Financial Burdens, Prescription Drug Expenses Compose the Largest Share of Out-of-Pocket Costs for Those with Chronic Conditions.
Section I: Characteristics of Construction Workers
Exhibit 1 Adults with High Needs Have Higher Health Care Spending and Out-of-Pocket Costs Average annual out-of-pocket spending Average annual health.
Medicare Household Spending Non-Medicare Household Spending
Of Adults with High Costs, Most Have Multiple Chronic Diseases, With or Without Functional Limitations Percent with high needs: Three or more chronic diseases,
Health Insurance.
Cumulative Change in Single and Family Health Insurance Premiums and Federal Poverty Level, * * *No data are available for 2007 due to MEPS transition.
How do health expenditures vary across the population?
1.03 Healthcare Finances.
Community Health Indicators
Share of State Variation in 2014 Employer Premiums Explained by Various Factors Notes: We conducted this analysis by regressing median premiums from the.
DISCUSS THE BASIC PRINCIPLES OF DIFFERENT INSURANCE PLANS
BURDEN OF ILLNESS IN CYSTIC FIBROSIS: A RETROSPECTIVE ANALYSIS OF MEDICAL EXPENDITURE PANEL SURVEY (MEPS) DATA Pratyusha Vadagam, MS Candidate,1 Khalid.
Volume 11, Issue 4, Pages (July 2011)
Percent of Total Health Care Spending
Methods of Payment for Healthcare
Ty Borders, PhD Director, Rural and Underserved Health Research Center
1.03 Healthcare Finances.
Adults with High Needs Have Unique Demographic Characteristics
Methods of Payment for Healthcare
Volume 11, Issue 4, Pages (July 2011)
1.03 Healthcare Finances.
Total adult population
October, 2018 Steven B. Cohen Ph.D. and Jamie Shorey, Ph.D.
Jessica Banthin, Ph.D December 11, 2007
Health Care Spending Was Higher at Every Level for Adults with High Needs Than for Adults with Multiple Chronic Diseases Only Total adult population Three.
Average annual out-of-pocket spending
1.03 Healthcare Finances.
Vice President, Health Care Coverage and Access
Community Health Indicators
Figure 1. Distribution of Individuals Covered by Private Health Insurance, by Type of Health Plan, 2005–2007 Comprehensive = health plan with no deductible.
Volume 11, Issue 4, Pages (July 2011)
Minnesota Health Care Spending and Cost Drivers
Chartbook Section 3 Employment-Based Health Insurance.
How do health expenditures vary across the population?
1.03 Healthcare Finances.
Only minor changes needed Fundamental changes needed
Access Problems Because of Cost
Module 5 HC Economics Students.
1.03 Healthcare Finances.
Households with employer coverage can spend thousands of dollars on premiums and out-of-pocket costs. Distribution of spending on premiums and out-of-pocket.
Heart Failure Currently, an estimated 5.7 million Americans are living with heart failure. An additional 670,000 new cases are diagnosed annually, up.
Figure 9. Americans’ Overall Views of the U. S
BLINDNESS, VISUAL IMPAIRMENT AND ACCESS TO CARE
Presentation transcript:

National Estimate of the cost of Parkinson’s Disease Medications 1999-2003 Katherine Anderson, PhD Uniformed Services University of the Health Sciences

Outline Objectives of the study Introduction Background and Significance Methods Results Conclusions and Discussion Questions

Objectives of the study Describe the cost of medications for patients with Parkinson's disease at a national and regional level Articulate payment sources and amounts for Parkinson's disease medications Discuss how demographic characteristics relate to the cost of Parkinson's disease medications

Introduction Limited Data No Cure One of the most expensive neurological diseases No Cure Goal of therapy 5 Categories of treatment

Background and Significance In 1900 only 3 million persons in the United States were over the age of 65 In 2000, 39 million were over 65 Population estimates for 2030 Parkinson’s has no cure Variety of pharmaceutical options

Previous Studies Cost Utility Analysis Cost Effectiveness Analysis

Methods Data Source- Medical Expenditures Panel Survey (MEPS) Population- Civilian, Non-institutionalized Software-SAS 9.13 Merging-Can be used when working with a sample size of less than 100 occurrences in a year Weighting- Each person in the survey is assigned a patient weight

MEPS Overlapping Panels: 2003 Annual File

Pooled Data Analysis File from MEPS-HC 1999-2003 Number of people reporting Parkinson’s disease medications Data Analysis File-2000 Number of people reporting Parkinson’s disease medications Data Analysis File-2003 Number of people reporting Parkinson’s disease medications Data Analysis File-2001 Number of people reporting Parkinson’s disease medications Data Analysis File-2002 Number of people reporting Parkinson’s disease medications Pooled Data Analysis File from MEPS-HC 1999-2003 An estimate of costs for Parkinson’s disease medications Figure 1. Merge of Five Years of MEPS-HC Data Files for a One-Year Pooled Estimate of Cost of Parkinson’s Disease Medications in the United States MEPS Data Files.

Demographics MEPS-HC Source: Agency for Healthcare Research and Quality. Medical Expenditures Panel Survey.

Results at a National Level A weighted total of 2.6 million people reported having prescriptions filled for Parkinson’s disease between 1999-2003. Just over 25 million prescriptions were filled for these patients The cost of the prescriptions were approximately $2 billion dollars

1999-2003 for Patients with Parkinson’s Disease. Un-weighted and Weighted Number and Cost of Prescription Medication from the MEPS-HC 1999-2003 for Patients with Parkinson’s Disease. Year Unweighted Number Weighted Number Unweighted Cost Weighted Cost 1999 330 5,092,013 $28,087 $420,603,519 2000 473 4,917,244 $37,121 $377,857,783 2001 613 5,301,378 $49,015 $398,453,297 2002 514 4,980,544 $37,912 $361,345,738 2003 432 4,764,877 $36,377 $422,955,793 Overall Total 2,362 25,056,056 $188,512 $1,981,216,130

Results at a Regional Level Northeast Midwest South West

Payment Sources and Amounts Yearly amount by source Five year amount by source 12 Sources of payment Medicaid Medicare Other Federal Other Private Other Insurance Other Public Private Insurance Self or Family State or Local Tricare Veterans Workers Comp

Source, Annual Amount, and Five Year Totals 1999 2000 2001 2002 2003 Source Total Medicare $20,837,538 $27,845,067 $ 22,471,245 $33,483,500 $15,715,290 $120,352,640 Private Insurance $94,021,764 $66,408,511 $21,545,292 $59,315,672 $137,243,216 $378,534,455 Self/Family $279,772104 $250,990,581 $334,199,748 $198,225,922 $243,957,332 $1,307,145,687 Veterans $25,972,113 $24,201,701 $3,418,511 $61,418,496 $18,704,018 $133,714,839 Medicaid $0 $8,411,923 $16,818,501 $8,902,148 $6,726,181 $40,858,753 Other Private $420,256 Tri-Care $189,500 Total $420,603,519 $377,857,783 $398,453,297 $361,345,738 $422,955,793 $1,981,216,130

Demographic Characteristics and Statistics Gender Age Marital Status Income Education Level Region

Conclusions and Discussion What we found and why So What? Future Studies

Thank You

Questions Katherine Anderson, PhD Assistant Professor, Uniformed Services University of the Health Sciences 4301 Jones Bridge Road A-2008 Bethesda, MD 20817 301-295-0112